China NT Pharma Ends Deal with Shanxi Ningle
Company Announcements

China NT Pharma Ends Deal with Shanxi Ningle

China NT Pharma Group Co., Ltd. (HK:1011) has released an update.

China NT Pharma Group Co., Ltd. has voluntarily announced the termination of their non-legally binding Memorandum of Understanding with Shanxi Ningle Pharmaceutical Logistics Co., Ltd. due to doubts about the credibility of Shanxi Ningle’s information and financial data. The company advised shareholders and potential investors to exercise caution when dealing with its shares following the termination of the proposed cooperation.

For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App